• Notifications
    This feature only available to registered users.
  • Alerts
    This feature only available to registered users
  • Welcome Guest!
  • Login Signup

Stock [ BUY ] / [ SELL ] Trading Strategies
. [ Show Details ]

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:

Indicator Windows:

ENZ [ Enzo Biochem Inc ]
Last Trade 1.97 Date 11/26/2020
Change % 0.51 % Price Change 0.01
Open 1.95 52 Week High 4.85
High 1.97 52 Week Low 1.56
Low 1.94 Type stock
Volume 134583 Average Volume 305985
Prev Close 1.96 Stock Exchange NYSE
Bid 1.94 Ask 2.06
Bid Size 5 Ask Size 1
1st Yr Estimated EPS Growth 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share 1.2189 Book Value Yield 0.6187
Buy Back Yield CAPE Ratio
Cash Return -0.2441 Cash Flow per Share -0.3602
Cash Flow Yield -0.1828 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield -0.3046 EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income
EV / Revenue 1.0428 EV / Total Asset 0.7045
Expected Dividend Growth Rate Free Cash Flow per Share -0.4057
Free Caash Flow Ratio Free Cash Flow Yield -0.2059
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio Payout Ratio 0.0
PB Ratio 1.616164 PB Ratio 10 Year Growth -0.011603
PB Ratio 3 Year Growth 2.271245 Cash Ratio 3 Year Average 311.572
Price to Cash Flow Ratio PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average 40.850958 PE Ratio 10 Year Growth
PE Ratio 10 Year High 142.5 PE Ratio 10 Year Low 5.226804
PE Ratio 1 Year Avg 101.233082 PE Ratio 1 Year High 142.5
PE Ratio 1 Year Low 52.4 PE Ratio 3 Year Avg 86.119841
PE Ratio 5 Year Avg 40.850958 PE Ratio 5 Year High 142.5
PE Ratio 5 Year Low 5.226804 Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg 175.270798 Price Change 1 Month 1.082418
Price to Cash Ratio 1.971237 Price / EBITDA
Price to Sales Ratio 1.235989 Price to Sales Ratio 10 Year Growth -0.034945
Price to Sales Ratio 3 Year Avg 1.899589 Price to Sales Ratio 5 Year Avg 40.850958
Sale per Share 1.5939 Sales Yield 0.8091
Sustainable Growth Rate -0.395 Tangible Book Value per Share 1.0521
Tangible Book Value per Share 3 year Avg 1.5227 Tangible Book Value per Share 5 year Avg 1.3944
Total Asset per Share 2.3497 Total Yield
Working Capital per Share 0.7509 Working Capital per Share 3 Year Avg 1.2929
Working Capital per Share 5 Year Avg 1.1938 Beta 0.812683
Company Profile

Enzo Biochem, Inc., a life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Enzo Life Sciences, Enzo Clinical Labs, and Enzo Therapeutics. The Enzo Life Sciences segment manufactures, develops, and markets functional biology and cellular biochemistry products and tools to research and pharmaceutical customers. It offers products applied in the fields of antibiotics, autophagy, cancer, cell cycle, cell death, cell signaling, cell trafficking, genomics/molecular biology, immunology, inflammation, lipid signaling, neurobiology, protein degradation, ROS/RNS, and stress/heat shock. The Enzo Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It also operates a full-service clinical laboratory, a network of 30 patient service centers, a stand alone or rapid response laboratory, and a full-service phlebotomy department. The Enzo Therapeutics segment engages in the research and development of various therapeutic drug candidates based on cell signaling, immune regulation, and gene regulation for the treatment of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem, Inc. sells its products through direct sales force and distributors in the United States, Switzerland, the United Kingdom, Belgium, and Germany. The company was founded in 1976 and is headquartered in New York, New York.